[1]于靓,王劲红,付小萌,等.前哨淋巴结检测在子宫内膜癌精准治疗中的 技术研究[J].中国计划生育和妇产科,2020,(1):69-72.
　YU Liang,WANG Jin-hong,FU Xiao-meng,et al.Technical study of sentinel lymph node detection in the precise treatment of endometrial cancer[J].Chinese Journal of Family Planning & Gynecotokology,2020,(1):69-72.
点击复制

前哨淋巴结检测在子宫内膜癌精准治疗中的 技术研究
分享到：

《中国计划生育和妇产科》[ISSN:1674-4020/CN:51-1708/R]

卷:
期数:
2020年1期
页码:
69-72
栏目:
论著与临床
出版日期:
2020-01-25

文章信息/Info

Title:
Technical study of sentinel lymph node detection in the precise treatment of endometrial cancer
作者:
于靓; 王劲红; 付小萌; 杨丹; 陈英超; 郭静; 贾东琪; 杜林; 姜娟*
哈尔滨市第一医院妇一科
Author(s):
YU Liang; WANG Jin-hong; FU Xiao-meng; YANG Dan; CHEN Ying-chao; GUO Jing; JIA Dong-qi; DU Lin; JIANG Juan*
Department of Gynecology, Harbin First Hospital, Harbin Heilongjiang 150000，P.R.China
关键词:
纳米碳示踪剂; 子宫内膜癌; 前哨淋巴结; 宫腔镜; 宫底联合宫颈
Keywords:
nano-carbon tracer;  endometrial cancer;  sentinel lymph nodes;  hysteroscopy;  uterine floor combined with cervical
分类号:
R 737.33
摘要:
目的探讨不同部位注射纳米碳示踪剂在子宫内膜癌前哨淋巴结(sentinel lymph node，SLN) 检测中的应用价值，探寻子宫内膜癌精准治疗中最优化的SLN示踪技术。方法选取2017年7月至2018年12月于哈尔滨市第一医院接受手术治疗的临床Ⅰ、Ⅱ期子宫内膜癌患者40例, 采用随机分组法分为宫底联合宫颈组（20例）和宫腔镜组（20例）。术中分别将纳米碳于宫底联合宫颈、宫腔镜下肿瘤周围子宫内膜多点注射，开腹或腹腔镜下观察显影的第一站淋巴结并将其切除单独送病理学检查，手术中分别记录染色 SLN 位置及数目，术后行病理学检查；之后所有患者均规范行子宫、附件切除及系统盆腔淋巴结清扫术或腹主动脉旁淋巴结取样术。比较两种方式用于子宫内膜癌SLN定位的检出率、准确率。结果40例患者SLN检出率为825 %，占切除淋巴结总数的186 %。SLN最常位于髂外区（357 %），然后依次为髂内（322 %）、髂总（175 %）、闭孔（91 %）、腹主动脉旁（42 %）和宫旁（14 %）。宫底联合宫颈组SLN术中检出率为90 %，宫腔镜组SLN检出率为85 %，两组间比较差异无统计学意义（P＞005）。SLN 示踪对子宫内膜癌区域淋巴结转移状况预测的准确率为90 %。结论宫底联合宫颈注射法与宫腔镜子宫内膜肿瘤注射法SLN检出率差异无统计学意义；宫底联合宫颈注射法敏感度好且操作简单、学习曲线短，具有较好的临床实用前景。SLN 基本可代表区域淋巴结转移状况，SLN示踪检测能明显提高子宫内膜癌手术的淋巴结清扫数量，提高肿瘤淋巴结转移的检出率，同时提高术后病理学分期的准确性。对于指导手术切除范围及指导术后治疗等方面具有重要意义。
Abstract:
ObjectiveTo explore the application value of carbon nano-tracers injected at different sites in the detection of sentinel lymph node(SLN) in endometrial cancer, and to explore the optimal SLN tracing technology for accurate treatment of endometrial cancer. MethodsA total of 40 patients with stage I and Ⅱ endometrial cancer who underwent surgical treatment at Harbin First Hospital from July 2017 to December 2018 were selected and randomly divided into the uterine floor combined with cervical group (20 cases) and endoscopic group (20 cases). During the operation, nano-carbon was injected into the uterine floor combined with cervical and endometrium around the tumor under hysteroscopy at multiple points, the first-stage lymph node was observed and resected separately for pathological examination. The position and number of stained SLNs were recorded during surgery, and pathological examinations were performed after operation. After that, all patients underwent hysterectomy, appendectomy, and systematic pelvic lymphadenectomy or abdominal aortic lymph node sampling. The detection rate and accuracy rate of SLN localization for endometrial cancer were compared. ResultsThe detection rate of SLN in 40 patients was 825 %, accounting for 186 % of the total number of resected lymph nodes. SLNs were most commonly located in the external iliac region (357 %), followed by intra-iliac (322 %), common iliac (175 %), obturator (91 %), para-aortic (42 %) and para-uterine (14 %).The detection rate of SLN in the uterine floor combined with cervical group was 90 %, and the detection rate of SLN in hysteroscopy group was 85%.There was no significant difference between the two groups (P>005). SLN tracing accurately predicted 90 % of lymph node metastasis in endometrial cancer. ConclusionThere was no significant difference in the detection rate of SLN between the uterine floor combined with cervical injection and hysteroscopic endometrial tumor injection. The combination of uterine floor and cervical injection has good sensitivity, simple operation, and short learning curve, which has a good clinical practice prospect. SLN can basically represent the status of regional lymph node metastasis. SLN tracer detection can significantly increase the number of lymph node dissections for endometrial cancer surgery, increase the detection rate of tumor lymph node metastases, and improve the accuracy of postoperative pathological staging. It is of great significance for guiding the scope of surgical resection and guiding postoperative treatment.

参考文献/References:

［1］Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015 ［J］. CA Cancer J Clin, 2015, 65(1):5-29. ［2］岳晓雪，苗劲蔚，杨淑丽，等.不同部位注射吲哚菁绿在子宫内膜癌前哨淋巴结定位中的应用 ［J］，中国医刊,2019,54（3）：295-298. ［3］Cragun JM, Havrilesky LJ, Calingaert B, et al. Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancer［J］. J Clin Oncol, 2005, 23(16):3668-3675. ［4］皇甫玉爽，郭健，宋晓晖．吲哚菁绿荧光检测在子宫内膜癌前哨淋巴结定位中的应用值 ［J］．实用妇产科杂志，2018，34（8）：609-612． ［5］于秀章，侯敏敏，郄明蓉．子宫内膜癌前哨淋巴结检测研究现状［J］．实用妇产科杂志，2018，34（5）：344-347． ［6］曹立娜，梁义娟．不同示踪剂识别子宫内膜癌中前哨淋巴结的研究进展 ［J］．中国生育健康杂志，2018，29（4）：393-395. ［7］Perrone AM, Casadio P, Formelli G, et al. Cervical and hysteroscopic injection for identifi cation of sentinel lymph node in endometrial cancer ［J］. Gynecol Oncol, 2008, 111(1):62-67. ［8］董晓红．不同部位注射（99m）Tc标记的肌醇六磷酸盐联合亚甲蓝检测早期子宫内膜癌前哨淋巴结的临床分析 ［J］．中国实用医药，2016，11（14）：151-152． ［9］王甜，胡元晶．前哨淋巴结在子宫内膜癌中应用的研究进展［J］．国际妇产科学杂志，2017，44（6）：671-676． ［10］王延洲，梁志清．前哨淋巴结检测在子宫内膜癌中的临床意义［J］．中国实用妇科与产科杂志，2017，33（5）：451-454. ［11］彭亦凡，姚云峰，王林，等． 纳米碳示踪剂标记前哨淋巴结在结肠癌根治术中的应用 ［J］． 中华普通外科杂志，2013，28（6)： 409－ 412． ［12］Jewell EL,Huang JJ,Abu-Rustum NR,et al. Detection of sentinel lymph nodes in minimally invasive surgery using indocyanine green and near-infrared fluorescence imaging for uterine and cervical malignancies ［J］. Gynecol Oncol, 2014, 133(2):274-277. ［13］Sinno AK, Fader AN, Roche KL, et al. A comparison of colorimetric versus fluorometric sentinel lymph node mapping during robotic surgery for endometrial cancer ［J］. Gynecol Oncol, 2014, 134(2):281-286. ［14］Mucke J, Klapdor R, Schneider M, et al. Isthmocervical labelling and SPECT/CT for optimized sentinel detection in endometrial cancer: technique,experience and results［J］. Gynecol Oncol, 2014, 134(2):287-292. ［15］Robova H, Rob L, Halaska MJ, et al. Current status of sentinel lymph node mapping in the management of endometrial cancer ［J］. Expert Rev Anticancer Ther, 2013, 13(1):55-61. ［16］李学伟，阴贵华，朱振庆. 术中不同部位注射生物染料检测乳腺癌前哨淋巴结的临床分析［J］. 中国疗养医学，2015，24（9）：932－933.

相似文献/References:

[1]胡玲,胡健蓉,徐凤仪,等.血管内皮生长因子在子宫内膜癌中的表达及其意义[J].中国计划生育和妇产科,2011,(01):0.
　HU Ling,HU Jian-rong,XU Feng-yi,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2011,(1):0.
[2]孙红敏,苑中甫.胰岛素样生长因子受体-1在子宫内膜癌组织中的表达及意义[J].中国计划生育和妇产科,2011,(02):0.
　SUN Hong-min,WAN Zhong-fu ..[J].Chinese Journal of Family Planning & Gynecotokology,2011,(1):0.
[3]田兆华,王建六.应客观评价腹膜后淋巴结切除在子宫内膜癌的治疗价值[J].中国计划生育和妇产科,2011,(03):0.
[4]陈晓丽.CD44v6、MMP-2在子宫内膜癌的表达及临床意义[J].中国计划生育和妇产科,2011,(03):0.
　CHEN Xiao-li.[J].Chinese Journal of Family Planning & Gynecotokology,2011,(1):0.
[5]梅彤,舒宽勇.CD133在子宫内膜癌中的研究进展[J].中国计划生育和妇产科,2012,(04):0.
　MEI Tong,SHU Kuan-yong* .Medical.[J].Chinese Journal of Family Planning & Gynecotokology,2012,(1):0.
[6]曹晓智,王小捷,李凤山,等.宫内膜细胞p16基因表达检测筛查子宫内膜癌的研究[J].中国计划生育和妇产科,2013,(06):0.
　Cao Xiao-zhi,Wang Xiao-jie,Li Feng-shan,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2013,(1):0.
[7]廖娟,杨菊生,李越,等.磁共振成像在Ⅰ、Ⅱ期子宫内膜癌术前分期中的应用分析[J].中国计划生育和妇产科,2014,(06):0.
　LIAO Juan,YANG Ju-sheng,LI Yue,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2014,(1):0.
[8]姜志欣,吴玉璘.女性人乳头瘤病毒感染及相关肿瘤[J].中国计划生育和妇产科,2014,(07):0.
[9]魏丽惠.关于子宫内膜癌筛查的思考[J].中国计划生育和妇产科,2015,(01):0.
[10]张超,蒋国庆.子宫内膜癌细胞学筛查的Meta分析[J].中国计划生育和妇产科,2015,(06):0.
　ZHANG Chao,JIANG Guo-qing,[J].Chinese Journal of Family Planning & Gynecotokology,2015,(1):0.

更新日期/Last Update: 2020-01-25